Misinformation about vaccines can hinder efforts to increase immunization rates.

Understanding the mechanisms that disrupt the quiescence of dormant disseminated cancer cells (DCCs) is crucial for addressing metastatic progression.

This first episode positions life course immunisation within the global health landscape, framing it alongside the UN Sustainable Development Goals, the WHO European Immunisation Agenda 2030 and broader health equity aims.

Influenza viruses pose a significant public health threat, causing seasonal epidemics and occasional pandemics with substantial morbidity and mortality worldwide.

Outbreaks of vaccine-preventable diseases are increasing at a time when funding for immunisation programmes is being cut.

Tissue repair programs must function alongside antiviral immunity to restore the lung epithelial barrier following infection. In response to influenza or viral mimic challenge, mice lacking OSM exhibited heightened IFN-I responses and increased mortality.

Recombinant neuraminidase (NA) has emerged as an antigenically conserved intranasal vaccine candidate, capable of inducing broad cross-protection, but it requires effective mucosal adjuvants.

High-dose influenza vaccine showed more immunogenicity in immunocompromised patients